Daniel Mulkerin
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 55
- Colorectal Cancer Treatments and Studies 27
- Cancer Treatment and Pharmacology 21
- Pancreatic and Hepatic Oncology Research 8
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Noelle K. LoConte (30 shared papers)Sam Joseph Lubner (26 shared papers)Chris H. Takimoto (13 shared papers)Kyle D. Holen (20 shared papers)Scot C. Remick (10 shared papers)Ramesh K. Ramanathan (8 shared papers)Merrill J. Egorin (7 shared papers)S. Percy Ivy (7 shared papers)
- Journals
- Journal of Clinical Oncology (29 papers)Investigational New Drugs (7 papers)Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)The Oncologist (3 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Daniel Mulkerin
74 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Oncology 670
- Hematology 209
- Genetics 121
- Hepatology 90
- Pathology and Forensic Medicine 155
Countries citing papers authored by Daniel Mulkerin
This map shows the geographic impact of Daniel Mulkerin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Mulkerin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Mulkerin more than expected).
Fields of papers citing papers by Daniel Mulkerin
This network shows the impact of papers produced by Daniel Mulkerin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Mulkerin. The network helps show where Daniel Mulkerin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Mulkerin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 106 | |
| 2 | 2003 | 95 | |
| 3 | 2011 | 72 | |
| 4 | 2008 | 70 | |
| 5 | 2015 | 59 | |
| 6 | 2012 | 59 | |
| 7 | 2007 | 56 | |
| 8 | 2004 | 50 | |
| 9 | 2002 | 47 | |
| 10 | 2015 | 44 | |
| 11 | 2007 | 38 | |
| 12 | 2016 | 36 | |
| 13 | 2011 | 35 | |
| 14 | 2014 | 33 | |
| 15 | 2008 | 28 | |
| 16 | 2003 | 26 | |
| 17 | 2011 | 19 | |
| 18 | 2019 | 18 | |
| 19 | 2021 | 17 | |
| 20 | 2010 | 17 |
About Daniel Mulkerin
Daniel Mulkerin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Epidemiology and Hematology, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (27 papers), Cancer Treatment and Pharmacology (21 papers), Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Treatments and Mutations (7 papers), Genetic factors in colorectal cancer (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Oncology (670 citations), Hematology (209 citations), Genetics (121 citations), Hepatology (90 citations) and Pathology and Forensic Medicine (155 citations). Daniel Mulkerin has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Noelle K. LoConte, Sam Joseph Lubner, Chris H. Takimoto, Kyle D. Holen, Scot C. Remick, Ramesh K. Ramanathan, Merrill J. Egorin, S. Percy Ivy, Sridhar Mani and Jens C. Eickhoff. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.